Jounce Therapeutics jouncetx.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Jounce Therapeutics is dedicated to transforming the treatment of cancer through discovering and developing novel cancer immunotherapies with the potential to drive significantly more durable responses to treatment, extending and improving patients' quality of life. Jounce utilizes translational science insights to match the right targets to well defined patient populations in order to achieve a higher probability of success and rapid proof-of-concept. The company is pursuing programs against mu...Show all

Jounce Therapeutics is dedicated to transforming the treatment of cancer through discovering and developing novel cancer immunotherapies with the potential to drive significantly more durable responses to treatment, extending and improving patients' ...Show all

Company (IPO / Went public)

All investors data 10 Investors

Phone: 857-259-3840

Fax:

1030 Massachusetts Ave

 Cambridge, 02138
 Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Jounce Therapeutics $240.8M Jan 27, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Jounce Therapeutics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors

Board Members

Name Firm
Login to see detailsThird Rock Ventures
Login to see detailsThird Rock Ventures
Login to see detailsThird Rock Ventures
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antibodies to pd-1 and uses thereof Nov 01, 2017 Application
Antibodies to icos Mar 22, 2016 Application
Antibodies that inhibit tim-3:lilrb2 interactions and uses thereof Jan 04, 2016 Application
Methods of treating conditions with antibodies that bind b7-h4 Oct 30, 2015 Application